Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 3024 results.
User Information
Export Records
  1. 1.   HIVGenoPipe: a nextflow pipeline for the detection of HIV-1 drug resistance using a real-time sample-specific reference sequence
  2. Dotrang,Thoai; Sherman,Brad; Dai,Lisheng; Khan,Muhammad; Highbarger,Helene; Bruchey,Whitney; Laverdure,Sylvain; Baseler,Michael; Imamichi,Tomozumi; Dewar,Robin; Chang,Weizhong
  3. BMC Bioinformatics. 2025, Jul 07; 26(1): 168.
  1. 2.   Prolonged antiretroviral therapy use and hypertension in a retrospective cross-sectional study-Rakai, Uganda
  2. Mongo Bua, Grace; Ssempijja,Victor; Ndyanabo, Anthony; Nabukalu, Dorean; Basiima, Jesca; Kankaka, Edward Nelson; Nalugoda, Fred; Nakigozi, Gertrude; Kagaayi, Joseph; Chang, Larry W; Post, Wendy S; Quinn, Thomas C; Gray, Ron; Wawer, Maria; Kigozi, Godfrey; Reynolds, Steven J
  3. BMC Infectious Diseases. 2025, Jul 01; 25(1): 860.
  1. 3.   Polymerase theta inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroids
  2. Teicher, Beverly A; Dexheimer,Thomas; Chen,Li; Silvers, Thomas; Jones,Eric; Coussens,Nathan; Eder, J Paul; Doroshow, James H
  3. Experimental and Molecular Pathology. 2025, Jun 27; 143: 104978.
  1. 4.   Antiproliferative Cassaine Diterpenoid Amines from the Leaves and Twigs of the Traditional Thai Medicinal Plant Erythrophleum teysmannii (Kurz) Craib
  2. Orfanoudaki,Maria; Wang,Dongdong; Du,Lin; Ruchirawat, Somsak; Kittakoop, Prasat; Grkovic,Tanja; Mahidol, Chulabhorn; O'Keefe,Barry
  3. Journal of Ethnopharmacology. 2025, Jun 25; 352: 120167.
  1. 5.   Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer
  2. Lassoued, Wiem; Madan, Ravi A; Xue, Elisabetta; Burnett, Daniel; Canubas, Kenneth D; Bailey, Shania; Marté, Jennifer L; Tsai, Yo-Ting; Donahue, Renee N; Turkbey, Ismail Baris; Papanicolau-Sengo, Antonios; Williams, Moniquea; Hankin, Amy; Manukyan,Manuk; Manu, Michell; Kang, Zhigang; Pritchard, Colin; Dahut, William; Karzai, Fatima; Schlom, Jeffrey; Sater, Sam; Pinto, Peter; Gulley, James L
  3. Journal for Immunotherapy of Cancer. 2025, Jun 22; 13(6):
  1. 6.   Benzosuberene and Tetracyclic Analogues as Colchicine Site Inhibitors of Tubulin Polymerization
  2. VanNatta, Jennifer M; Carlson, Graham J; Niu, Haichan; Bai, Ruoli; Wanniarachchi, Hashini I; Schuetze, Regan; Trawick, Mary Lynn; Hamel,Ernest; Mason, Ralph P; Pinney, Kevin G
  3. ACS Medicinal Chemistry Letters. 2025, Jun 12; 16(6): 1098-1107.
  1. 7.   Large Congenital Melanocytic Nevus With LMNA::NTRK1 Fusion: Expanding Targeted Therapy Options for Congenital Nevi and Melanoma
  2. Nagarkar, Akanksha; Turbeville, Jackson; Hinshaw, Molly A; LeBoit, Philip E; Gagan, Jeffrey; Raffeld, Mark; Aldape, Kenneth; Shah, Niharika; Barr, Frederic G; Xi, Liqiang; Lee, Ina; Ferrone, Christina K; Pack, Svetlana D; Kaplan, Rosandra; Malone, Mary Frances Wedekind; Yohe,Marielle; Sargen, Michael R
  3. Journal of Cutaneous Pathology. 2025, Jun 03;
  1. 8.   Neovascular pruning by IDO1 inhibitors can potentiate immunogenic cytotoxicity of ischemia-targeted agents to synergistically enhance anti-PD-1 responsiveness
  2. Shen, Shih-Chun; Dey, Souvik; DuHadaway, James B; Sutanto-Ward, Erika; Hampton, Maurice T; Kozlov,Serguei; Prendergast, George C; Muller, Alexander J
  3. Journal for Immunotherapy of Cancer. 2025, May 30; 13(5):
  1. 9.   Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas
  2. O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Rubinstein, Larry V; Wilsker,Deborah; Moore, Nancy; Hogu, Murielle; Piekarz, Richard; Covey, Joe; Beumer, Jan H; Ferry-Galow,Katherine; Villaruz, Liza C; Hollingshead,Melinda; Holleran, Julianne L; Deppas, Joshua J; Pommier, Yves; Ko, Brian; Johnson, Barry C; Parchhment, Ralph E; Ivy, Percy; Doroshow, James H; Chen, Alice P
  3. Cancer Chemotherapy and Pharmacology. 2025, May 29; 95(1): 58.
  1. 10.   Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series
  2. Sargen, Michael R; Fitzhugh, Madeline H; Ko, Jennifer S; Close, Allison G; Horton, Sara C; Malik, Faizan; Furtado, Larissa V; Bahrami, Armita; Seynnaeve, Brittani K N; Pappo, Alberto S; Liu, Vincent; Cheung, Kevin; Pack, Svetlana D; Xi, Liqiang; Raffeld, Mark; Lee, Ina; Gagan, Jeffrey; Aldape, Kenneth; Barr, Frederic G; Hewitt, Stephen M; Ferrone, Christina K; Hayden, Anna; Hatton, Jessica N; Goldstein, Alisa M; Pfeiffer, Ruth M; Widemann, Brigitte; Malone, Mary Frances Wedekind; Gross, Andrea M; Kaplan, Rosandra; Yohe,Marielle; Berrebi, Kristen G
  3. Pediatric Blood & Cancer. 2025, May 19; e31814.
  1. 11.   m276-SL-PBD eradicates tumors and instigates long-lasting tumor-free survival in Merkel cell carcinoma preclinical models
  2. Kunika, Mikaela D; Kannan, Aarthi; Velasco, Graham J; Feng,Yang; Seaman,Steven; Das, Bhaba K; Pham, Dillon; Lambrecht, Nils; Zhao, Haibo; St Croix,Bradley; Gao, Ling
  3. iScience. 2025, May 16; 28(5): 112436.
  1. 12.   Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
  2. Pang, Ying; Li, Qi; Sergi, Zach; Yu, Guangyang; Kim, Olga; Lu, Peng; Chan, Marina; Sang, Xueyu; Wang, Herui; Ranjan, Alice; Robey, Robert W; Soheilian, Ferri; Tran,Bao; Núñez, Felipe J; Zhang, Meili; Song, Hua; Zhang, Wei; Davis, Dionne; Gilbert, Mark R; Gottesman, Michael M; Liu, Zhenggang; Thomas, Craig J; Castro, Maria G; Gujral, Taranjit S; Wu, Jing
  3. iScience. 2025, Apr 18; 28(4): 112283.
  1. 13.   CDK2 Inhibition Produces a Persistent Population of Polyploid Cancer Cells
  2. Tyutyunyk-Massey, Liliya; Chen,Zibo; Liu,Xiuxia; Kawakami, Masanori; Harned,Adam; Ng, Yeap; Harned,Adam; Okpechi,Samuel; Ogunlade,Blessing; Alfaro Mora,Yair; Weigert, Roberto; Narayan,Kedar; Liu,Xi; Dmitrovsky,Ethan
  3. JCI Insight. 2025, Apr 15;
  1. 14.   Developmental onset of planarian whole-body regeneration depends on axis reset
  2. Booth, Clare L T; Stevens, Brian C; Stubbert, Clover A; Kallgren,Neil; Deihl,Ennis; Davies,Erin
  3. Current Biology : CB. 2025, Apr 11;
  1. 15.   Ror gamma t-positive dendritic cells are required for the induction of peripheral regulatory T cells in response to oral antigens
  2. Rodrigues, Patrick Fernandes; Wu, Shitong; Trsan, Tihana; Panda, Santosh K; Fachi, José Luís; Liu, Yizhou; Du, Siling; de Oliveira, Sarah; Antonova, Alina Ulezko; Khantakova, Darya; Sudan, Raki; Desai, Pritesh; Diamond, Michael S; Gilfillan, Susan; Anderson,Stephen; Cella, Marina; Colonna, Marco
  3. Cell. 2025, Apr 01;
  1. 16.   Discovery of potent and selective PROTACs for the protein kinase LZK for the treatment of head and neck cancer
  2. Katerji,Meghri; Bergman, Knickole L; Lindberg, Eric; Rubin,Maxine; Funk, Amy L; Woodroofe, Carolyn C; Nyswaner, Katherine; Karpinska, Kamila; Serwa, Remigiusz; Marusiak, Anna; Swenson, Rolf E; Brognard,John
  3. The Journal of Biological Chemistry. 2025, Mar 27; 108452.
  1. 17.   PLS-a-GalCer: a novel targeted glycolipid therapy for solid tumors
  2. Burks, Julian; Tiwary, Shweta; Stevens, David M; Skoczen,Sarah; Kularatne,Ruvanthi Nilanga; Stern,Stephan; Berzofsky, Jay A
  3. Journal for Immunotherapy of Cancer. 2025, Mar 22; 13(3):
  1. 18.   PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer
  2. Floudas, Charalampos S; Goswami, Meghali; Donahue, Renee N; Strauss, Julius; Pastor, Danielle M; Redman, Jason M; Brownell, Isaac; Turkbey, Evrim B; Steinberg, Seth M; Cordes, Lisa M; Marté, Jennifer L; Khan, Maheen H; McMahon, Sheri; Lamping, Elizabeth; Manu,Michell; Manukyan,Manuk; Brough, Douglas E; Lankford, Amy; Jochems, Caroline; Schlom, Jeffrey; Gulley, James L
  3. Cancer Immunology, Immunotherapy : CII. 2025, Mar 21; 74(5): 155.
  1. 19.   Inhibition of Ribosome Biogenesis in vivo Causes p53-Dependent Death and p53-Independent Dysfunction
  2. Cho, Charles J; Nguyen, Thanh; Rougeau, Amala K; Huang, Yang-Zhe; To, Sarah; Lin, Xiaobo; Thalalla Gamage,Supuni; Meier,Jordan; Mills, Jason C
  3. Cellular and Molecular Gastroenterology and Hepatology. 2025, Mar 11; 101496.
  1. 20.   Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
  2. Happe, Myra; Lynch, Rebecca M; Fichtenbaum, Carl J; Heath, Sonya L; Koletar, Susan L; Landovitz, Raphael J; Presti, Rachel M; Santana-Bagur, Jorge L; Tressler, Randall L; Holman, LaSonji A; Novik, Laura; Roa, Jhoanna C; Rothwell, Ro Shauna; Strom, Larisa; Wang,Jing; Hu, Zonghui; Conan-Cibotti, Michelle; Bhatnagar, Anjali M; Dwyer, Bridget; Ko, Sung Hee; Belinky, Frida; Namboodiri, Aryan M; Pandey, Janardan P; Carroll, Robin; Basappa, Manjula; Serebryannyy, Leonid; Narpala, Sandeep R; Lin, Bob C; McDermott, Adrian B; Boritz, Eli A; Capparelli, Edmund V; Coates, Emily E; Koup, Richard A; Ledgerwood, Julie E; Mascola, John R; Chen, Grace L; Tebas, Pablo
  3. JCI Insight. 2025, Feb 24; 10(4):
  1. 21.   Histidine Tag-Specific PEGylation Improves the Circulating Half-Life of TIMP2
  2. Toor, Jack; Grabowska, Wiktoria R; Johnson, Adam L; Jones,Jane; Stetler-Stevenson, William G; Khalili, Hanieh; Peeney, David
  3. ACS Applied Bio Materials. 2025, Feb 21;
  1. 22.   Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial
  2. Cecchini, Michael; Pilat, Mary Jo; Uboha, Nataliya; Azad, Nilofer S; Cho, May; Davis, Elizabeth J; Ahnert, Jordi Rodon; Tinoco, Gabriel; Shapiro, Geoffrey I; Khagi, Simon; Powers, Benjamin; Spencer, Kristen; Groisberg, Roman; Drappatz, Jan; Chen, Li; Das,Bishu; Bao, Xun; Li, Jing; Narayan, Azeet; Vu, Dennis; Patel, Abhijit; Niger, Monica; Doroshow, Deborah; Durecki, Diane; Boerner, Scott A; Bindra, Ranjit; Ivy, Percy; Shyr, Derek; Shyr, Yu; LoRusso, Patricia M
  3. Cancer. 2025, Feb 15; 131(4): e35755.
  1. 23.   Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350
  2. Joyce, M Gordon; Bu, Wei; Chen, Wei-Hung; Gillespie, Rebecca A; Andrews, Sarah F; Wheatley, Adam K; Tsybovsky,Yaroslav; Jensen, Jaime L; Stephens,Tyler; Prabhakaran, Madhu; Fisher, Brian E; Narpala, Sandeep R; Bagchi, Meghna; McDermott, Adrian B; Nabel, Gary J; Kwong, Peter D; Mascola, John R; Cohen, Jeffrey I; Kanekiyo, Masaru
  3. Immunity. 2025, Feb 11; 58(2): 295-308.e5. .
  1. 24.   Modulation of the Substrate Preference of a MYST Acetyltransferase by a Scaffold Protein
  2. Sengupta, Raghuvir N; Brodsky, Oleg; Bingham, Patrick; Diehl, Wade C; Ferre, RoseAnn; Greasley, Samantha E; Johnson, Eric; Kraus, Michelle; Lieberman, Whitney; Meier,Jordan; Paul, Thomas A; Maegley, Karen A
  3. The Journal of Biological Chemistry. 2025, Feb 03; 108262.
  1. 25.   Longitudinal single-cell profiles of lung regeneration after viral infection reveal persistent injury-associated cell states
  2. Niethamer, Terren K; Planer, Joseph D; Morley, Michael P; Babu, Apoorva; Zhao, Gan; Basil, Maria C; Cantu, Edward; Frank, David B; Diamond, Joshua M; Nottingham, Ana N; Li, Shanru; Sharma,Arnav; Hallquist, Hannah; Levin, Lillian I; Zhou, Su; Vaughan, Andrew E; Morrisey, Edward E
  3. Cell Stem Cell. 2025, Jan 13;
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel